The DEEP project has received research funding from the European Union under the 7th Framework Programme
The 5th DEEP General Assembly took place from the 3rd to the 5th of July 2014 in the legendary city of Athens, Greece, with the participation of the whole DEEP Consortium as well as external experts. The main contents presented and discussed are summarized below.
Session I […]
On January 31st, 2013 recruitment started in the DEEP-1 study (multi-centre, oral single dose experimental and modelling study to evaluate the pharmacokinetics of deferiprone in patients aged from 1 month to less than 6 years of age affected by transfusion-dependent haemoglobinopathies) and the first patient […]
On February 15th 2013 recruitment started for the DEEP-3 study (multi-centre, long-term observational safety study to evaluate the nature and incidence of adverse effects of deferiprone treatment in patients with beta-thalassaemia major aged from 1 month to less than 18 years). The first patient […]
